Replimune Group Inc
For the period ended Mar 31, 2024. Filed May 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed May 16, 2024
REPL$22.26+3.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated statements of operations F-
| Year Ended March 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Operating expenses: | ||
| Research and development | $174,963 | $126,527 |
| Selling, general and administrative | 59,810 | 50,553 |
| Total operating expenses | 234,773 | 177,080 |
| Loss from operations | (234,773) | (177,080) |
| Other income (expense): | ||
| Research and development incentives | 1,920 | 2,914 |
| Investment income | 23,356 | 10,006 |
| Interest expense on finance lease liability | (2,163) | (2,197) |
| Interest expense on debt obligations | (4,497) | (1,963) |
| Other income (expense) | 771 | (5,676) |
| Total other income, net | 19,387 | 3,084 |
| Loss before income taxes | $(215,386) | $(173,996) |
| Income tax provision | 408 | 288 |
| Net loss | $(215,794) | $(174,284) |
| Net loss per common share, basic and diluted | $(3.24) | $(2.99) |
| Weighted average common shares outstanding, basic and diluted | 66,569,894 | 58,213,010 |
F - 5
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.